This compound is an Fmoc-protected derivative of alpha-methyl-2-fluoro-D-phenylalanine, used as a building block in solid-phase peptide synthesis. Its protected amino group and sterically hindered structure enable incorporation of non-standard amino acid residues into synthetic peptides.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1315449-93-4
3-(2,6-difluorophenyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-propanoic acid
pharmaceutical intermediate
(S)-N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-C-ALPHA-METHYL-2,6-DIFLUOROPHENYLALANINE
research compound
Fmoc-N-methyl-L-isoleucine
pharmaceutical intermediate
Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH
pharmaceutical intermediate
Fmoc-L-propargylglycine
pharmaceutical intermediate
3-[[(Acetylamino)methyl]thio]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valine
pharmaceutical intermediate
Fmoc-Alpha-Me-Orn(Boc)-OH
pharmaceutical intermediate
2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-5-pyrimidineacetamide
pharmaceutical intermediate
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(2-fluorophenyl)-2-methylpropanoic acid
VNYGHKCAXQKZEQ-RUZDIDTESA-N
C[C@@](CC1=CC=CC=C1F)(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24